Interestingly, contrary to expectations, increased expression of ROBO4 has been associated with improved overall survival in patients with non-small-cell lung cancer (NSCLC) [33], indicating a potential protective role for ROBO4 in NSCLC progression. Here, ROBO4 is linked to non-small cell lung carcinoma.